These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6632428)

  • 1. [Evaluation of antiplatelet drug therapy and replaced heart valves based on platelet functions].
    Nasu M; Shikano K; Miyamura K; Shinpo H; Morimoto T; Ohi T; Shomura S; Yamazaki N; Yada I; Kusagawa M
    Kyobu Geka; 1983 Sep; 36(9):701-5. PubMed ID: 6632428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-thromboembolic therapy and effects of dipyridamole on platelet function in patients with heart valve prostheses (authors transl)].
    Tokumo M; Doko S; Ono Y; Takabatake T; Noguchi A; Omoto T; Teramoto S
    Kyobu Geka; 1978; 31(1):19-22. PubMed ID: 628105
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Persantine in preventing thromboembolism following valve replacement.
    Arrants JE; Hairston P
    Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
    Ben Ismail M; Ghariani M; Jais JM
    Nouv Presse Med; 1975 Mar; 4(10):746 (2). PubMed ID: 1129046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Should all prosthetic valve patients be treated by platelet inhibitors?].
    Lévy G; Bordes F; Mariottini P; François G
    Nouv Presse Med; 1976 Jan; 5(5):251-4. PubMed ID: 1264682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PT-INR as a parameter for anticoagulant therapy after valve replacement surgery].
    Ishibashi Y; Aoki H; Ohba J; Kamikubo Y; Morimoto K; Kumasaka A
    Kyobu Geka; 1996 Oct; 49(11):906-8. PubMed ID: 8913062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
    Boda Z; Voith L; Udvardy M; Hársfalvi J; Pfliegler G; Tornai I
    Orv Hetil; 1987 Feb; 128(5):239-42. PubMed ID: 3547248
    [No Abstract]   [Full Text] [Related]  

  • 9. Clotted Bjork-Shiley mitral valve prostheses: early detection and surgical management.
    Sabbagh AH
    Cardiovasc Res Cent Bull; 1983; 21(4):101-7. PubMed ID: 6883419
    [No Abstract]   [Full Text] [Related]  

  • 10. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Miller MM; Hipp R; Matsumura ME
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1167-9. PubMed ID: 18669529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The St Jude medical valve - the Australian experience.
    Hunt D; Sloman G; Sutton L
    Med J Aust; 1981 Sep; 2(6):276-8. PubMed ID: 7300758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Remote results of prosthesis of 3 cardiac valves (mitral, aortic and tricuspid)].
    Martsinkiavichius AM; Paliushchinskaia NA; Sirvidis VM; Zhukauskaĭte GA; Mil'vidaĭte AS
    Grudn Khir; 1980; (6):17-20. PubMed ID: 7450537
    [No Abstract]   [Full Text] [Related]  

  • 17. Early clinical experience with the carpentier-Edwards porcine heterograft cardiac valve.
    Jamieson WR; Janusz MT; Munro AI; Miyagishima RT; Tutassura H; Gerein AN; Burr LH; Allen P
    Can J Surg; 1980 Mar; 23(2):132-7. PubMed ID: 7363173
    [No Abstract]   [Full Text] [Related]  

  • 18. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Bockeria LA; Skopin II; Kuts EV
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-aggregant therapy in subjects with a cardiac valve prosthesis and under treatment with oral anticoagulants].
    Raucci D; Caso P; Gualtieri S; Iarussi D; Jacono A
    Boll Soc Ital Cardiol; 1979; 24(3):265-72. PubMed ID: 548104
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombosis prevention and platelet functions following heart valve replacement].
    Aosaki M; Kitamura N
    Nihon Rinsho; 1978 Dec; 36(12):3874-83. PubMed ID: 372627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.